Legal status in Germany
No EU Novel Food authorization. Selling NMN as a supplement in Germany is not compliant with EU law. Personal import is generally unhindered.
Approval and regulatory body
No marketing authorization with BfArM or EMA. NMN is not a drug. Its primary regulatory dimension is Novel Food.
Scheduling
Not listed in BtMG. Not listed in DmMV.
Doping (WADA) status
WADA prohibited list 2026: not listed. See the official WADA Prohibited List.
Prescription reality
None. NMN has no drug authorization in Germany or the EU and is not available via any prescription pathway.
Compounding pharmacy nuance
Not applicable.
Research-use legal basis
NMN is freely sold as a laboratory chemical or research reagent. The legal issue is solely about marketing it as a food supplement for human consumption.
Import & customs in Germany
Selling NMN as a food supplement anywhere in the EU is non-compliant. Some vendors continue to ship while their Novel Food applications are pending.
Non-EU personal import
Personal-quantity imports from non-EU sources are generally not blocked by AMG (NMN is not a medicinal product) and are not blocked by Novel Food rules (which target sellers, not individual buyers). Customs may still inspect shipments labeled as supplements.
Research import
Permitted as a research chemical to laboratories or businesses with REACH compliance.
Typical seizure outcome
Rare. Personal-quantity NMN packages typically clear customs without issue. Commercial-quantity shipments to German sellers face higher enforcement risk.
Get the EU Compound Legality Map 2026 — every compound, every country, one PDF.
One PDF. Every compound. Every country. Updated quarterly.
Market reality on the ground
Pharmacy availability: Not stocked by Apotheken as a supplement. Some compounding pharmacies have refused to source it.
Telehealth pathway: Not applicable.
Domestic research-chem sellers: Widely available from German and EU-shipping vendors, often labeled 'laboratory chemical' or 'research use only' to sidestep Novel Food enforcement.
Underground use: High brand recognition in German longevity and biohacking communities driven by international media coverage. Used widely as part of NAD+ optimization protocols.
| Source | Indicative price (NMN) |
|---|---|
| EU research-grade vendor | €30–€80 per 30-day supply at 300–500 mg/day dosing equivalent |
| US imported (before seizure risk) | €40–€100 per 30-day supply after shipping |
Prices are observational ranges as of May 8, 2026, not endorsements. We do not link to research-chemical sellers.
Where DOSED stands on this
NMN sold in Germany carries a "research chemical, not for human consumption" label for a reason. The compound has no marketing authorization, no clinical trials registered, and no Apotheken pathway. The label is not marketing — it is the legal status. We do not provide dosing protocols, route-of-administration guidance, or vendor referrals. We do not make medical claims about safety or efficacy. We catalog the regulatory reality so you can make informed decisions, then point you to a licensed physician for any health decision that involves your body.
The aim here is the same one in every DOSED page: evidence over influence. Whatever you decide is on you. Our job is to make sure the decision is informed.
Building a stack and not sure what's legal where you live?
Building a stack and not sure what's legal where you live? Get a Stack Audit — we review your protocol against EU regulations, evidence quality, and compound interactions.
Frequently asked questions
Same compound, other countries
Other compounds in Germany
Editorial deep-dives
Get the EU Compound Legality Map 2026 — every compound, every country, one PDF.
One PDF. Every compound. Every country. Updated quarterly.
Sources & data verification
Last updated May 8, 2026. Reviewed every 3 months.
- EC Novel Food Consultation Status (checked 2026-05-08)
- EU Novel Food Regulation 2015/2283 (checked 2026-05-08)
- CIRS Group NMN regulatory update Dec 2025 (checked 2026-05-08)
- WADA Prohibited List 2026 (checked 2026-05-08)